- Caterina Ferreli,
- Giulia Gasparini,
- Aurora Parodi,
- Emanuele Cozzani,
- Franco Rongioletti,
- Laura Atzori
Clin Rev Allergy Immunol 2017 Jul 16. Epub 2017 Jul 16.
Section of Dermatology, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Scleroderma refers to an autoimmune connective tissue fibrosing disease, including three different subsets: localized scleroderma, limited cutaneous systemic sclerosis, and diffuse cutaneous systemic sclerosis with divergent patterns of organ involvement, autoantibody profiles, management, and prognostic implications. Although systemic sclerosis is considered the disease prototype that causes cutaneous sclerosis, there are many other conditions that can mimic and be confused with SSc. They can be classified into immune-mediated/inflammatory, immune-mediated/inflammatory with abnormal deposit (mucinoses), genetic, drug-induced and toxic, metabolic, panniculitis/vascular, and (para)neoplastic disorders according to clinico-pathological and pathogenetic correlations. Read More